Renal Business Today

Shorter Hepatitis C Treatment Effective

CHAPEL HILL, N.C. – A new multinational study found that a 24-week treatment course for hepatitis C that adds telaprevir to peginterferon alfa and ribavirin is just as effective as a 48-week regimen for many patients, according to a study published in the Sept. 15 issue of ...More

September 15, 2011

Posted in News, Clinical & Pharma

Incivek Improves Hepatitis C Treatment

NEW YORK—The drug telaprevir (Incivek) provides a dramatic improvement in the treatment of the most common form of hepatitis C infection, says an international team of investigators led by Dr. Ira M. Jacobson of NewYork-Presbyterian Hospital/Weill Cornell Medical Center. ...More

June 23, 2011

Posted in News, Clinical & Pharma

Patients Support Universal Screening for Hepatitis C

SEATTLE—In the United States, up to 70 percent of 2.9 million to 3.7 million people with hepatitis C (HCV) are unaware of their infection. Although universal screening might be a cost-effective way to identify infections, prevent morbidity, and reduce transmission, few ...More

June 9, 2011

Posted in News, Clinical & Pharma, Practice Management

FDA Approves Incivek for Hepatitis C

WASHINGTON—The U.S. Food and Drug Administration (FDA) has approved Incivek (telaprevir) to treat certain adults with chronic hepatitis C infection. ...More

May 24, 2011

Posted in News, Clinical & Pharma, Government & Regulation

CDC Warns Against Infection Risk From Fingerstick Devices

WASHINGTON—The Centers for Disease Control and Prevention (CDC) is increasingly concerned about the risks for transmitting hepatitis B virus (HBV) and other bloodborne pathogens to people using fingerstick procedures for blood sampling, such as diabetics who require ...More

September 1, 2010

Posted in News, Clinical & Pharma, Practice Management

Baxter Faces New Challenge in Heparin Suit

The Wall Street Journal today reported that Baxter International Inc. faces a new challenge in federal court regarding Baxter’s bid to block disclosure of documents about the contaminated-heparin situation of 2007 and 2008. The crisis involved contaminated Chinese heparin ...More

August 17, 2010

Posted in News, Clinical & Pharma

New Antiviral Drug May Improve Hepatitis C Treatment

The addition of a direct-acting anti-viral drug to the standard treatment regimen for hepatitis C significantly increases the cure rate in the most difficult-to-treat patients, according to a report published Monday in the online edition of the journal The Lancet. ...More

August 9, 2010

Posted in News, Clinical & Pharma

Natalie Cole Gets a New Kidney

LOS ANGELES—R&B singer Natalie Cole received a new kidney from a deceased donor on May 19 and is resting comfortably, her spokeswoman said May 20. ...More

May 21, 2009

Posted in News, Business, Clinical & Pharma, Practice Management

Computers & Software	Consulting, Management...
Equipment & Services	Hemodialysis Supplies
Patient Services	More Options...

Hepatitis

Mobile Health Snaps

Galleries

Most Popular Articles

Buyer's Guide

Resources

Free Email Updates

featured links

First Name	Last Name
E-Mail